Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Carcinoma, Merkel Cell × Carboplatin × Clear all

Phase

Status

Recruiting 1 Not yet recruiting 1 Completed 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Carcinoma, Non-Small-Cell Lung 338 Ovarian Neoplasms 176 Lung Neoplasms 171 Breast Neoplasms 119 Fallopian Tube Neoplasms 86 Neoplasms 79 Carcinoma, Ovarian Epithelial 69 Squamous Cell Carcinoma of Head and Neck 51 Small Cell Lung Carcinoma 47 Triple Negative Breast Neoplasms 41 Adenocarcinoma of Lung 41 Head and Neck Neoplasms 40 Neoplasm Metastasis 37 Neuroblastoma 34 Central Nervous System Neoplasms 33 Endometrial Neoplasms 28 Esophageal Neoplasms 27 Brain Neoplasms 27 Lymphoma 26 Carcinoma 26 Recurrence 25 Lymphoma, Large B-Cell, Diffuse 25 Urinary Bladder Neoplasms 24 Parkinson Disease 4, Autosomal Dominant Lewy Body 23 Adenocarcinoma, Bronchiolo-Alveolar 23 Testicular Neoplasms 22 Astrocytoma 22 Melanoma 19 Lymphoma, Non-Hodgkin 18 Uterine Cervical Neoplasms 17

Interventions

Nivolumab 6 pembrolizumab 5 Ipilimumab 4 Radiotherapy 3 talimogene laherparepvec 2 budigalimab 2 avelumab 2 atezolizumab 2 Everolimus 2 Cyclophosphamide 2 zimberelimab 1 venetoclax 1 vatalanib 1 tremelimumab 1 temsirolimus 1 sapanisertib 1 rovalpituzumab tesirine 1 poly ICLC 1 oblimersen 1 lorvotuzumab mertansine 1 lanreotide 1 glucopyranosyl lipid-A 1 fludarabine 1 durvalumab 1 domatinostat 1 cixutumumab 1 cemiplimab 1 aldesleukin 1 Vinorelbine 1 Surgical Procedures, Operative 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01013779 2022-11-18

MP3

Trans Tasman Radiation Oncology Group

Phase 2 Completed

Carcinoma, Merkel Cell

Data powered by HemOnc (CC BY 4.0) Colophon ⚡